Quest Diagnostics announced that it has completed the previously announced acquisition of lab-related clinical outreach service operations of Dignity Health, a hospital system based in California.

Quest Diagnostics will perform testing for the acquired operations through its clinical laboratories in West Hills and Sacramento, Calif., and Las Vegas, Nevada. The acquisition includes patient service centers and associated business in parts of California and Nevada. Dignity Health's hospital-based laboratories are not included in the sale. Additional terms were not disclosed.

Quest Diagnostics continues to expect the transaction to be neutral to adjusted earnings in 2013 and modestly accretive to earnings per share in 2014. The company also expects it to contribute about half a percentage point to consolidated revenues annually.

The acquisition, which is the company's third of a laboratory business in 2013, is consistent with the five-point strategy described by Quest Diagnostics late last year. This strategy includes delivering disciplined capital deployment and driving one to two percent in growth per year through strategically aligned fold-in acquisitions. In May, the company announced it had acquired the toxicology and clinical laboratory business of medical center operator Concentra, a subsidiary of Humana Inc. In January, the company completed the acquisition of the clinical and anatomic-pathology outreach laboratory businesses of Massachusetts-based UMass Memorial Medical Center.

RELATED ARTICLES

Black men diagnosed with prostate cancer classified as low risk may actually have a more aggressive form of the disease that is more likely to be fatal than in nonblack men placed in the same prognostic category, a new study suggests.

Inexpensive 3-D-printed microfluidics device could be used to personalize cancer treatment. A key feature in this MIT-designed device was using a new biocompatible resin — traditionally used for dental applications — that can support long-term survival of biopsied tissue.